Thursday, February 7th, 2013...4:55 pm
Q4 2012 Drug Sales Data Released: Abilify Overtakes Nexium as the Top Drug by Sales
The latest U.S. drug sales data have been released by Drugs.com. At the close of 2012, Otsuka’s antipsychotic Abilify overtakes AstraZeneca’s acid reducer Nexium and moves into the number one spot with over $1.47 billion in quarterly sales. Sales expanded for all five front-runners over the quarter, although none reached double-digit growth. There are no changes in the top selling pharmaceutical classes, which include antipsychotics, proton pump inhibitors, and statins.
View the data here…
View the press release here…